Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

WM Choi; TC Yip; GL Wong; WR Kim; LJ Yee; C Brooks-Rooney; T Curteis; H Cant; CY Chen; CY Chen; YH Huang; YJ Jin; DW Jun; JW Kim; NH Park; CY Peng; YS Lim

doi:10.1016/j.jhep.2022.12.007

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

WM Choi
, TC Yip
, GL Wong
, WR Kim
, LJ Yee
, C Brooks-Rooney
, T Curteis
, H Cant
, CY Chen
, CY Chen
, YH Huang
, YJ Jin
, DW Jun
, JW Kim
, NH Park
, CY Peng
, YS Lim

Division of Informatics, Imaging & Data Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	Journal of hepatology
DOIs	https://doi.org/10.1016/j.jhep.2022.12.007
Publication status	Published - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jhep.2022.12.007

Cite this

Choi, WM., Yip, TC., Wong, GL., Kim, WR., Yee, LJ., Brooks-Rooney, C., Curteis, T., Cant, H., Chen, CY., Chen, CY., Huang, YH., Jin, YJ., Jun, DW., Kim, JW., Park, NH., Peng, CY., & Lim, YS. (2022). Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis. Journal of hepatology. https://doi.org/10.1016/j.jhep.2022.12.007

@article{5596e68b7d1a4eaba96fe8867c795f0e,

title = "Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.",

author = "WM Choi and TC Yip and GL Wong and WR Kim and LJ Yee and C Brooks-Rooney and T Curteis and H Cant and CY Chen and CY Chen and YH Huang and YJ Jin and DW Jun and JW Kim and NH Park and CY Peng and YS Lim",

year = "2022",

month = dec,

doi = "10.1016/j.jhep.2022.12.007",

language = "Undefined",

journal = "Journal of hepatology",

issn = "0168-8278",

publisher = "Elsevier BV",

}

Choi, WM, Yip, TC, Wong, GL, Kim, WR, Yee, LJ, Brooks-Rooney, C, Curteis, T, Cant, H, Chen, CY, Chen, CY, Huang, YH, Jin, YJ, Jun, DW, Kim, JW, Park, NH, Peng, CY & Lim, YS 2022, 'Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.', Journal of hepatology. https://doi.org/10.1016/j.jhep.2022.12.007

TY - JOUR

T1 - Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

AU - Choi, WM

AU - Yip, TC

AU - Wong, GL

AU - Kim, WR

AU - Yee, LJ

AU - Brooks-Rooney, C

AU - Curteis, T

AU - Cant, H

AU - Chen, CY

AU - Huang, YH

AU - Jin, YJ

AU - Jun, DW

AU - Kim, JW

AU - Park, NH

AU - Peng, CY

AU - Lim, YS

PY - 2022/12

Y1 - 2022/12

UR - http://europepmc.org/abstract/med/36572349

U2 - 10.1016/j.jhep.2022.12.007

DO - 10.1016/j.jhep.2022.12.007

M3 - Article

C2 - 36572349

SN - 0168-8278

JO - Journal of hepatology

JF - Journal of hepatology

ER -

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

UN SDGs

Access to Document

Other files and links

Cite this